欧盟EMA药品数据库
(European Medicines Agency Authorisation of Medicines DataBase)
商品名称 通用名称 活性成分 产品号 上市许可持有人/公司名称 上市批准日期 授权状态
COVID-19 Vaccine Janssen COVID-19 vaccine (Ad26.COV2-S [recombinant]) adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S) EMEA/H/C/005737 Janssen-Cilag International NV 2021/03/11 Authorised
Heplisav B hepatitis B surface antigen hepatitis B surface antigen EMEA/H/C/005063 Dynavax GmbH 2021/02/18 Authorised
Ogluo glucagon Glucagon EMEA/H/C/005391 Xeris Pharmaceuticals Ireland Limited 2021/02/11 Authorised
Yuflyma adalimumab adalimumab EMEA/H/C/005188 Celltrion Healthcare Hungary Kft. 2021/02/11 Authorised
Tukysa tucatinib Tucatinib EMEA/H/C/005263 Seagen B.V. 2021/02/11 Authorised
Lenalidomide Krka lenalidomide lenalidomide hydrochloride monohydrate EMEA/H/C/005734 Krka, d.d., Novo mesto  2021/02/11 Authorised
Lenalidomide Krka d.d. Novo mesto lenalidomide lenalidomide hydrochloride monohydrate EMEA/H/C/005348 Krka, d.d., Novo mesto  2021/02/11 Authorised
Lenalidomide Krka d.d. lenalidomide lenalidomide hydrochloride hydrate EMEA/H/C/005729 Krka, d.d., Novo mesto  2021/02/11 Authorised
Lumoxiti moxetumomab pasudotox Moxetumomab pasudotox EMEA/H/C/005322 AstraZeneca AB 2021/02/08 Authorised
Inrebic fedratinib fedratinib dihydrochloride monohydrate EMEA/H/C/005026 Celgene Europe BV  2021/02/08 Authorised
Kixelle insulin aspart insulin aspart EMEA/H/C/004965 Mylan IRE Healthcare Limited 2021/02/05 Authorised
Rukobia fostemsavir fostemsavir trometamol EMEA/H/C/005011 ViiV Healthcare B.V. 2021/02/04 Authorised
Vaxzevria (previously COVID-19 Vaccine AstraZeneca) COVID-19 Vaccine (ChAdOx1-S [recombinant]) ChAdOx1-SARS-COV-2 EMEA/H/C/005675 AstraZeneca AB 2021/01/29 Authorised
Enhertu trastuzumab deruxtecan trastuzumab deruxtecan EMEA/H/C/005124 Daiichi Sankyo Europe GmbH 2021/01/18 Authorised
Onbevzi bevacizumab bevacizumab EMEA/H/C/005640 Samsung Bioepis NL B.V. 2021/01/11 Authorised
Elzonris tagraxofusp tagraxofusp EMEA/H/C/005031 Stemline Therapeutics B.V. 2021/01/07 Authorised
Xofluza baloxavir marboxil Baloxavir marboxil EMEA/H/C/004974 Roche Registration GmbH 2021/01/07 Authorised
Roclanda latanoprost / netarsudil Latanoprost, Netarsudil mesilate EMEA/H/C/005107 Aerie Pharmaceuticals Ireland Limited 2021/01/07 Authorised
COVID-19 Vaccine Moderna COVID-19 mRNA Vaccine (nucleoside modified) CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2) EMEA/H/C/005791 Moderna Biotech Spain, S.L. 2021/01/06 Authorised
Comirnaty COVID-19 mRNA vaccine (nucleoside-modified) Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2 EMEA/H/C/005735 BioNTech Manufacturing GmbH 2020/12/21 Authorised

数据库说明:

©2006-2021 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase